A 74-year-old man presented with progressive dyspnea on exertion. History included peripheral arterial disease and coronary artery bypass grafting with aortic valve replacement 12 years ago. Subsequently, the surgical valve developed severe stenosis and moderate insufficiency. He underwent a transapical valve-in-valve transcatheter aortic valve replacement 5 years before presentation. This second valve developed a mean gradient of 66 mm Hg with mild insufficiency. The patient was treated with a third aortic valve using an alternative transcaval approach, significantly alleviating his symptoms.
JohnstonD.R., SolteszE.G., VakilN.Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg.2015; 99: 1239–1247.
2.
DaubertM.A., WeissmanN.J., HahnR.T.Long-term valve performance of TAVR and SAVR: a report from the PARTNER I trial. JACC Cardiovasc Imaging.2017; 10: 15–25.
3.
DvirD., WebbJ., BreckerS.Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-invalve registry. Circulation.2012; 126: 2335–2344.
4.
GreenbaumA.B., BabaliarosV.C., ChenM.Y.Transcaval access and closure for transcatheter aortic valve replacement: a prospective investigation. J Am Coll Cardiol.2017; 69: 511–521.
5.
Rodriguez-GabellaT., VoisineP., PuriR., PibarotP., Rodés-CabauJ.Aortic bioprosthetic valve durability incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol.2017; 70: 1013–1028.
6.
DvirD.First look at long-term durability of transcatheter heart valves: assessment of valve function up to 10 years. Paper presented at: EuroPCR 2016; May 19, 2016. Paris, France.
MartinC., SunW.Transcatheter valve underexpansion limits leaflet durability: implications for valve-in-valve procedures. Ann Biomed Eng.2017; 45: 394–404.
9.
BlackstoneE.H., SuriR.M., RajeswaranJ.Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation.2015; 131: 1989–2000.
10.
BiancariF., RosatoS., D'ErrigoP.Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement. Am J Cardiol.2016; 117: 245–251.
